Ketamine Completed Phase 2 Trials for Traumas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03233035Low Dose Ketamine Intra Nasal Traumatology